The biopharma contract manufacturing market has grown at a compound annual rate approaching 10% during the past three years, according to HighTech Business Decisions forecasts, and the market will reach $2.8 billion this year. In response to this higher demand, many CMOs are adding new capacity. HighTech Business Decisions projects total biopharma contract production capacity to increase 15% during the next two years.   In the recently published industry study, “Biopharmaceutical Contract Manufa...